|
CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
1.935e-17 |
1.00
|
HEPS_HUMAN |
HPN |
Serine protease hepsin |
7.806e-07 |
1.00
|
CAC1B_RAT |
Cacna1b |
Voltage-dependent N-type calcium channel subunit alpha-1B |
1.262e-93 |
0.48
|
AMYP_PIG |
AMY2 |
Pancreatic alpha-amylase |
2.176e-91 |
0.39
|
CACB1_RAT |
Cacnb1 |
Voltage-dependent L-type calcium channel subunit beta-1 |
6.45e-81 |
0.48
|
CA2D2_RAT |
Cacna2d2 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 |
9.345e-81 |
0.48
|
CACB1_HUMAN |
CACNB1 |
Voltage-dependent L-type calcium channel subunit beta-1 |
9.345e-81 |
0.48
|
DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
2.842e-74 |
0.48
|
CAC1A_HUMAN |
CACNA1A |
Voltage-dependent P/Q-type calcium channel subunit alpha-1A |
4.384e-73 |
0.48
|
CA2D1_RAT |
Cacna2d1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
1.088e-54 |
0.46
|
SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
7.598e-52 |
0.51
|
FAAH1_HUMAN |
FAAH |
Fatty-acid amide hydrolase 1 |
2.863e-49 |
0.48
|
CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
2.434e-47 |
0.48
|
SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
1.184e-46 |
0.39
|
SC6A3_RAT |
Slc6a3 |
Sodium-dependent dopamine transporter |
1.527e-44 |
0.43
|
SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
1.629e-44 |
0.54
|
ACKR3_HUMAN |
ACKR3 |
Atypical chemokine receptor 3 |
1.997e-41 |
0.39
|
DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
2.108e-40 |
0.39
|
NMUR1_HUMAN |
NMUR1 |
Neuromedin-U receptor 1 |
9.264e-40 |
0.32
|
NMUR2_HUMAN |
NMUR2 |
Neuromedin-U receptor 2 |
7.271e-37 |
0.32
|
DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
1.772e-35 |
0.51
|
OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
2.375e-35 |
0.45
|
SC6A4_RAT |
Slc6a4 |
Sodium-dependent serotonin transporter |
1.312e-34 |
0.43
|
SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
2.554e-33 |
0.37
|
DRD1_BOVIN |
DRD1 |
D(1A) dopamine receptor |
2.92e-33 |
0.40
|
WNK1_HUMAN |
WNK1 |
Serine/threonine-protein kinase WNK1 |
1.219e-31 |
0.31
|
ACES_MOUSE |
Ache |
Acetylcholinesterase |
2.654e-30 |
0.40
|
GP183_HUMAN |
GPR183 |
G-protein coupled receptor 183 |
3.79e-30 |
0.42
|
PA24A_HUMAN |
PLA2G4A |
Cytosolic phospholipase A2 |
4.371e-29 |
0.33
|
TYTR_TRYBB |
TPR |
Trypanothione reductase |
2.66e-28 |
0.34
|
DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
1.84e-26 |
0.49
|
OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
7.179e-25 |
0.57
|
US28_HCMVA |
US28 |
G-protein coupled receptor homolog US28 |
4.112e-23 |
0.32
|
MGLL_MOUSE |
Mgll |
Monoglyceride lipase |
4.846e-23 |
0.34
|
FAAH1_RAT |
Faah |
Fatty-acid amide hydrolase 1 |
4.914e-23 |
0.40
|
5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
2.619e-22 |
0.47
|
ACES_ELEEL |
ache |
Acetylcholinesterase |
6.125e-21 |
0.42
|
SCN4A_HUMAN |
SCN4A |
Sodium channel protein type 4 subunit alpha |
2.129e-20 |
0.33
|
DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
6.07e-19 |
0.47
|
OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
1.35e-18 |
0.45
|
PA_I000X |
PA |
Polymerase acidic protein |
1.406e-18 |
0.36
|
AUKBA_XENLA |
aurkb-a |
Aurora kinase B-A |
4.879e-18 |
0.29
|
EBPL_HUMAN |
EBPL |
Emopamil-binding protein-like |
4.879e-18 |
0.29
|
SOS1_HUMAN |
SOS1 |
Son of sevenless homolog 1 |
4.879e-18 |
0.29
|
MGLL_HUMAN |
MGLL |
Monoglyceride lipase |
7.831e-18 |
0.36
|
NOX5_HUMAN |
NOX5 |
NADPH oxidase 5 |
1.544e-17 |
0.29
|
Q9WTR4_RAT |
Slc6a2 |
Transporter |
1.553e-17 |
0.39
|
OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
1.715e-17 |
0.45
|
5HT2A_PIG |
HTR2A |
5-hydroxytryptamine receptor 2A |
3.67e-17 |
0.39
|
CHKA_HUMAN |
CHKA |
Choline kinase alpha |
3.901e-17 |
0.34
|
RGS8_HUMAN |
RGS8 |
Regulator of G-protein signaling 8 |
4.169e-17 |
0.31
|
DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
1.11e-16 |
0.32
|
Q8HY88_BOVIN |
KCNK2 |
Potassium channel subfamily K member 2 |
4.441e-16 |
0.40
|
ACES_HUMAN |
ACHE |
Acetylcholinesterase |
5.551e-16 |
0.42
|
PDIA1_HUMAN |
P4HB |
Protein disulfide-isomerase |
7.772e-16 |
0.31
|
AL3A1_HUMAN |
ALDH3A1 |
Aldehyde dehydrogenase, dimeric NADP-preferring |
9.992e-16 |
0.37
|
SC6A4_MOUSE |
Slc6a4 |
Sodium-dependent serotonin transporter |
1.11e-15 |
0.30
|
SC6A3_HUMAN |
SLC6A3 |
Sodium-dependent dopamine transporter |
1.554e-15 |
0.44
|
Q9HUN3_PSEAE |
dnaB |
Replicative DNA helicase |
1.998e-15 |
0.34
|
PA_I34A1 |
PA |
Polymerase acidic protein |
2.554e-15 |
0.36
|
CHLE_HORSE |
BCHE |
Cholinesterase |
3.22e-15 |
0.36
|
HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
7.661e-15 |
0.40
|
ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
1.621e-14 |
0.44
|
CY24B_HUMAN |
CYBB |
Cytochrome b-245 heavy chain |
1.688e-14 |
0.29
|
RGS4_HUMAN |
RGS4 |
Regulator of G-protein signaling 4 |
1.932e-14 |
0.33
|
5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
2.243e-14 |
0.44
|
S6A12_HUMAN |
SLC6A12 |
Sodium- and chloride-dependent betaine transporter |
5.584e-14 |
0.34
|
CCR8_HUMAN |
CCR8 |
C-C chemokine receptor type 8 |
9.77e-14 |
0.37
|
ACHP_LYMST |
|
Acetylcholine-binding protein |
1.742e-13 |
0.33
|
HMOX2_RAT |
Hmox2 |
Heme oxygenase 2 |
1.892e-13 |
0.40
|
LSS_HUMAN |
LSS |
Lanosterol synthase |
2.386e-13 |
0.37
|
AAKG1_HUMAN |
PRKAG1 |
5'-AMP-activated protein kinase subunit gamma-1 |
2.992e-13 |
0.34
|
DRD1_PIG |
DRD1 |
D(1A) dopamine receptor |
4.284e-13 |
0.39
|
PLPL6_MOUSE |
Pnpla6 |
Neuropathy target esterase |
5.718e-13 |
0.30
|
Q8VH26_CAVPO |
GPM3 |
Muscarinic acetylcholine receptor |
1.299e-12 |
0.38
|
CASP5_HUMAN |
CASP5 |
Caspase-5 |
2.217e-12 |
0.35
|
HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
2.446e-12 |
0.37
|
ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
3.463e-12 |
0.44
|
AAPK2_HUMAN |
PRKAA2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 |
5.932e-12 |
0.34
|
AAKB1_HUMAN |
PRKAB1 |
5'-AMP-activated protein kinase subunit beta-1 |
7.949e-12 |
0.34
|
SC6A4_HUMAN |
SLC6A4 |
Sodium-dependent serotonin transporter |
8.324e-12 |
0.44
|
SC6A2_HUMAN |
SLC6A2 |
Sodium-dependent noradrenaline transporter |
1.046e-11 |
0.44
|
ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
2.83e-11 |
0.44
|
KCNJ6_HUMAN |
KCNJ6 |
G protein-activated inward rectifier potassium channel 2 |
3.105e-11 |
0.33
|
RCE1_YEAST |
RCE1 |
CAAX prenyl protease 2 |
4.517e-11 |
0.40
|
MGLL_RAT |
Mgll |
Monoglyceride lipase |
5.485e-11 |
0.32
|
5HT1A_HUMAN |
HTR1A |
5-hydroxytryptamine receptor 1A |
5.583e-11 |
0.39
|
CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
7.136e-11 |
0.40
|
CA2D1_HUMAN |
CACNA2D1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
9.832e-11 |
0.48
|
ABHD6_MOUSE |
Abhd6 |
Monoacylglycerol lipase ABHD6 |
1.23e-10 |
0.30
|
DRD2_CHLAE |
DRD2 |
D(2) dopamine receptor |
1.835e-10 |
0.32
|
CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
2.4e-10 |
0.39
|
Q63380_RAT |
NET |
Transporter |
4.043e-10 |
0.41
|
HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
4.754e-10 |
0.51
|
OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
4.922e-10 |
0.60
|
GP183_MOUSE |
Gpr183 |
G-protein coupled receptor 183 |
5.473e-10 |
0.28
|
CP19A_RAT |
Cyp19a1 |
Aromatase |
5.511e-10 |
0.41
|
SC6A3_MOUSE |
Slc6a3 |
Sodium-dependent dopamine transporter |
7.265e-10 |
0.30
|
ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
8.511e-10 |
0.44
|
KCNJ5_HUMAN |
KCNJ5 |
G protein-activated inward rectifier potassium channel 4 |
1.155e-09 |
0.33
|
INHA_MYCTU |
inhA |
Enoyl-[acyl-carrier-protein] reductase [NADH] |
1.407e-09 |
0.40
|
GP139_HUMAN |
GPR139 |
Probable G-protein coupled receptor 139 |
1.479e-09 |
0.30
|
CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
2.743e-09 |
0.37
|
DCNL1_HUMAN |
DCUN1D1 |
DCN1-like protein 1 |
3.212e-09 |
0.34
|
AROK_HELPY |
aroK |
Shikimate kinase |
4.864e-09 |
0.28
|
ADA2A_RAT |
Adra2a |
Alpha-2A adrenergic receptor |
4.901e-09 |
0.36
|
NK1R_HUMAN |
TACR1 |
Substance-P receptor |
5.204e-09 |
0.44
|
KCNJ3_HUMAN |
KCNJ3 |
G protein-activated inward rectifier potassium channel 1 |
5.477e-09 |
0.33
|
CAC1I_HUMAN |
CACNA1I |
Voltage-dependent T-type calcium channel subunit alpha-1I |
7.559e-09 |
0.40
|
PARP1_MOUSE |
Parp1 |
Poly [ADP-ribose] polymerase 1 |
1.093e-08 |
0.34
|
GPR6_HUMAN |
GPR6 |
G-protein coupled receptor 6 |
1.319e-08 |
0.37
|
5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
3.685e-08 |
0.37
|
ACES_RAT |
Ache |
Acetylcholinesterase |
5.087e-08 |
0.42
|
SKN1_CAEEL |
skn-1 |
Protein skinhead-1 |
5.218e-08 |
0.31
|
S6A13_MOUSE |
Slc6a13 |
Sodium- and chloride-dependent GABA transporter 2 |
8.176e-08 |
0.29
|
ACM1_RAT |
Chrm1 |
Muscarinic acetylcholine receptor M1 |
1.075e-07 |
0.36
|
PE2R4_HUMAN |
PTGER4 |
Prostaglandin E2 receptor EP4 subtype |
1.301e-07 |
0.34
|
NPY2R_HUMAN |
NPY2R |
Neuropeptide Y receptor type 2 |
1.336e-07 |
0.35
|
CTBP2_HUMAN |
CTBP2 |
C-terminal-binding protein 2 |
1.346e-07 |
0.30
|
5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
1.462e-07 |
0.44
|
MCHR1_RAT |
Mchr1 |
Melanin-concentrating hormone receptor 1 |
1.476e-07 |
0.33
|
SCN2A_RAT |
Scn2a |
Sodium channel protein type 2 subunit alpha |
1.619e-07 |
0.40
|
S12A5_RAT |
Slc12a5 |
Solute carrier family 12 member 5 |
2.67e-07 |
0.31
|
NOX4_HUMAN |
NOX4 |
NADPH oxidase 4 |
2.756e-07 |
0.31
|
XCT_HUMAN |
SLC7A11 |
Cystine/glutamate transporter |
3.05e-07 |
0.28
|
ACPS_BACSU |
acpS |
Holo-[acyl-carrier-protein] synthase |
3.053e-07 |
0.30
|
S12A2_HUMAN |
SLC12A2 |
Solute carrier family 12 member 2 |
3.071e-07 |
0.31
|
MC4R_HUMAN |
MC4R |
Melanocortin receptor 4 |
3.459e-07 |
0.43
|
LOX5_HUMAN |
ALOX5 |
Arachidonate 5-lipoxygenase |
4.443e-07 |
0.48
|
SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
5.069e-07 |
0.30
|
VACHT_TETCF |
|
Vesicular acetylcholine transporter |
6.414e-07 |
0.39
|
O97467_PLAFA |
ht1 |
Hexose transporter 1 |
6.86e-07 |
0.37
|
NLRP3_HUMAN |
NLRP3 |
NACHT, LRR and PYD domains-containing protein 3 |
7.111e-07 |
0.46
|
O61059_LEIME |
LmGT2 |
Glucose transporter |
7.666e-07 |
0.37
|
CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
9.753e-07 |
0.37
|
PRIO_SHEEP |
PRNP |
Major prion protein |
1.017e-06 |
0.31
|
CHLE_HUMAN |
BCHE |
Cholinesterase |
1.159e-06 |
0.36
|
5HT4R_CAVPO |
HTR4 |
5-hydroxytryptamine receptor 4 |
1.175e-06 |
0.32
|
PCP_HUMAN |
PRCP |
Lysosomal Pro-X carboxypeptidase |
1.31e-06 |
0.32
|
PDR5_YEAST |
PDR5 |
Pleiotropic ABC efflux transporter of multiple drugs |
1.359e-06 |
0.29
|
SERA_HUMAN |
PHGDH |
D-3-phosphoglycerate dehydrogenase |
1.507e-06 |
0.30
|
OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
1.553e-06 |
0.60
|
NOX1_HUMAN |
NOX1 |
NADPH oxidase 1 |
2.454e-06 |
0.29
|
CCR1_HUMAN |
CCR1 |
C-C chemokine receptor type 1 |
2.972e-06 |
0.34
|
ACM5_RAT |
Chrm5 |
Muscarinic acetylcholine receptor M5 |
3.133e-06 |
0.28
|
OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
3.589e-06 |
0.54
|
S6A12_MOUSE |
Slc6a12 |
Sodium- and chloride-dependent betaine transporter |
3.847e-06 |
0.29
|
MIF_HUMAN |
MIF |
Macrophage migration inhibitory factor |
4.103e-06 |
0.32
|
BRSK2_HUMAN |
BRSK2 |
Serine/threonine-protein kinase BRSK2 |
4.596e-06 |
0.29
|
CAC1H_HUMAN |
CACNA1H |
Voltage-dependent T-type calcium channel subunit alpha-1H |
6.102e-06 |
0.40
|
CAC1C_CAVPO |
CACNA1C |
Voltage-dependent L-type calcium channel subunit alpha-1C |
6.64e-06 |
0.37
|
GTR1_HUMAN |
SLC2A1 |
Solute carrier family 2, facilitated glucose transporter member 1 |
8.707e-06 |
0.37
|
KCNH2_HUMAN |
KCNH2 |
Potassium voltage-gated channel subfamily H member 2 |
8.956e-06 |
0.40
|
PE2R1_HUMAN |
PTGER1 |
Prostaglandin E2 receptor EP1 subtype |
9.237e-06 |
0.33
|